Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma.

about

Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations.

P2860

Q43095122-A4404B83-0DE9-45AE-990A-1B946FCE2045

P2860

Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma.

Item

http://www.wikidata.org/entity/Q38982260

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Synergistic chemotherapeutic e ...... ainst murine breast carcinoma.

@en

type

Item

label

Synergistic chemotherapeutic e ...... ainst murine breast carcinoma.

@en

prefLabel

Synergistic chemotherapeutic e ...... ainst murine breast carcinoma.

@en

P1476

Synergistic chemotherapeutic e ...... gainst murine breast carcinoma

@en

P2093

Hanxu Cai

http://www.w3.org/2001/XMLSchema#string

Jie Liang

http://www.w3.org/2001/XMLSchema#string

Junhui Sui

http://www.w3.org/2001/XMLSchema#string

Ling Zhou

http://www.w3.org/2001/XMLSchema#string

Shaoquan Bian

http://www.w3.org/2001/XMLSchema#string

Xingdong Zhang

http://www.w3.org/2001/XMLSchema#string

Yani Cui

http://www.w3.org/2001/XMLSchema#string

Yong Sun

http://www.w3.org/2001/XMLSchema#string

Zhiyi Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells.

Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation.

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer.

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial.

Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma

Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.

Molecular targeted therapies in hepatocellular carcinoma

P304

2755-2767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C6NR09639E

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yujiang Fan

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28155940

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma.

about

P2860

P2860

Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921